Hongbo Qi
University of Science and Technology of China(CN)Inner Mongolia University(CN)Hefei National Center for Physical Sciences at Nanoscale(CN)Microscale (United States)(US)Northwest A&F University(CN)
Publications by Year
Research Areas
Catalytic C–H Functionalization Methods, Catalytic Cross-Coupling Reactions, Neuropeptides and Animal Physiology, Catalytic Alkyne Reactions, Receptor Mechanisms and Signaling
Most-Cited Works
- → Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity(2006)122 cited
- → Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1 S,2 S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents(2007)101 cited
- → 2(S)-((3,5-Bis(trifluoromethyl)benzyl)oxy)-3(S)-phenyl-4-((3-oxo-1,2,4-triazol- 5-yl)methyl)morpholine (1): A Potent, Orally Active, Morpholine-Based Human Neurokinin-1 Receptor Antagonist(1996)67 cited
- → Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes(2015)23 cited
- → A one-pot synthesis of 3-substituted-5-carbonylmethyl-1,2,4-oxadiazoles from β-keto esters and amidoximes under solvent-free conditions(2007)22 cited